de la Fuente M - Search Results

1

Platelet specific promoters are insufficient to express protease activated receptor 1 (PAR1) transgene in mouse platelets.

Arachiche A, de la Fuente M, Nieman MT. Arachiche A, et al. Among authors: de la fuente m. PLoS One. 2014 May 15;9(5):e97724. doi: 10.1371/journal.pone.0097724. eCollection 2014. PLoS One. 2014. PMID: 24830314 Free PMC article.

2

Targeting the anionic region of human protease-activated receptor 4 inhibits platelet aggregation and thrombosis without interfering with hemostasis.

Mumaw MM, de la Fuente M, Noble DN, Nieman MT. Mumaw MM, et al. Among authors: de la fuente m. J Thromb Haemost. 2014 Aug;12(8):1331-41. doi: 10.1111/jth.12619. Epub 2014 Jun 27. J Thromb Haemost. 2014. PMID: 24888424 Free PMC article.

3

Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets.

Arachiche A, de la Fuente M, Nieman MT. Arachiche A, et al. Among authors: de la fuente m. PLoS One. 2013;8(2):e55740. doi: 10.1371/journal.pone.0055740. Epub 2013 Feb 6. PLoS One. 2013. PMID: 23405206 Free PMC article.

4

Protease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin.

Arachiche A, Mumaw MM, de la Fuente M, Nieman MT. Arachiche A, et al. Among authors: de la fuente m. J Biol Chem. 2013 Nov 8;288(45):32553-32562. doi: 10.1074/jbc.M113.472373. Epub 2013 Oct 4. J Biol Chem. 2013. PMID: 24097976 Free PMC article.

5

Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4).

Mumaw MM, de la Fuente M, Arachiche A, Wahl JK 3rd, Nieman MT. Mumaw MM, et al. Among authors: de la fuente m. Thromb Res. 2015 Jun;135(6):1165-71. doi: 10.1016/j.thromres.2015.03.027. Epub 2015 Apr 9. Thromb Res. 2015. PMID: 25890453 Free PMC article.

6

Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human platelets.

Han X, de la Fuente M, Nieman MT. Han X, et al. Among authors: de la fuente m. Res Pract Thromb Haemost. 2020 Dec 4;5(1):104-110. doi: 10.1002/rth2.12459. eCollection 2021 Jan. Res Pract Thromb Haemost. 2020. PMID: 33537534 Free PMC article.

7

Mapping human protease-activated receptor 4 (PAR4) homodimer interface to transmembrane helix 4.

de la Fuente M, Noble DN, Verma S, Nieman MT. de la Fuente M, et al. J Biol Chem. 2012 Mar 23;287(13):10414-10423. doi: 10.1074/jbc.M112.341438. Epub 2012 Feb 8. J Biol Chem. 2012. PMID: 22318735 Free PMC article.

8

Expression and Purification of Protease-Activated Receptor 4 (PAR4) and Analysis with Histidine Hydrogen-Deuterium Exchange.

de la Fuente M, Han X, Miyagi M, Nieman MT. de la Fuente M, et al. Biochemistry. 2020 Feb 11;59(5):671-681. doi: 10.1021/acs.biochem.9b00987. Epub 2020 Jan 24. Biochemistry. 2020. PMID: 31957446

9

Murine cadherin-6 mediates thrombosis in vivo in a platelet-independent manner.

Bouck EG, de la Fuente M, Zunica ER, Li W, Mumaw MM, Nieman MT. Bouck EG, et al. Among authors: de la fuente m. Res Pract Thromb Haemost. 2020 Dec 4;5(1):125-131. doi: 10.1002/rth2.12458. eCollection 2021 Jan. Res Pract Thromb Haemost. 2020. PMID: 33537536 Free PMC article.

10

Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells.

Montano MM, Yeh IJ, Chen Y, Hernandez C, Kiselar JG, de la Fuente M, Lawes AM, Nieman MT, Kiser PD, Jacobberger J, Exner AA, Lawes MC. Montano MM, et al. Among authors: de la fuente m. Breast Cancer Res. 2019 Dec 5;21(1):138. doi: 10.1186/s13058-019-1228-7. Breast Cancer Res. 2019. PMID: 31805991 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

917 results

Search Page

Filters